Retatrutide Results UK — What to Expect Week by Week
What results should you realistically expect from retatrutide? This guide breaks down the clinical trial outcomes week by week, explains how individual results vary, and sets honest expectations for UK buyers starting a retatrutide protocol.
Retatrutide Phase 2 Results — The Clinical Evidence
The gold standard for retatrutide results comes from the Phase 2 trial published in the New England Journal of Medicine (2023), which followed 338 adults across four dose groups over 48 weeks:
| Retatrutide Dose | Average Weight Loss | % Losing ≥15% | % Losing ≥20% |
|---|---|---|---|
| 4mg | 8.7% | 30% | 14% |
| 8mg | 17.3% | 61% | 43% |
| 12mg | 22.8% | 73% | 57% |
| 24mg | 24.2% | 79% | 83% |
For comparison: semaglutide 2.4mg (Wegovy®) produced 14.9% average weight loss in the STEP 1 trial. Tirzepatide 15mg (Mounjaro®) produced 22.5% in SURMOUNT-1.
Retatrutide Results Week by Week — Typical Timeline
Weeks 1–4 (2mg starting dose)
Most users notice subtle changes — slightly smaller appetite, meals feeling satisfying with less food. Don’t expect dramatic weight loss at the starting dose. This phase is about allowing your body to adapt. Average weight change: 0.5–1kg loss.
Weeks 5–8 (4mg dose)
Appetite suppression becomes clearer. Spontaneous reduction in calorie intake without intentional dieting. Average weight loss: 1–2kg over this period.
Weeks 9–12 (8mg dose)
This is typically where users notice the most significant change. Appetite is substantially reduced. Many report “food noise” diminishing — fewer intrusive thoughts about food. Average weight loss accelerates to 2–3kg per month at this stage.
Weeks 13–24 (12mg dose)
Peak weight loss phase for most users. Strong appetite suppression, increased energy expenditure from glucagon activation. Users who started at 100kg are typically at 80–85kg by week 24 on 12mg. Cumulative average: 15–22% body weight.
Week 24+ (Maintenance at 12–24mg)
Weight loss continues at a slower rate as the body approaches a new set point. Focus shifts to maintenance. At 24mg, the Phase 2 trial showed 24.2% average total weight loss at week 48.
Real Weight Loss Calculator — How Much Could You Lose?
Based on Phase 2 trial averages at the 12mg maintenance dose:
- Starting weight 80kg: Expected loss ~18kg → target weight ~62kg
- Starting weight 100kg: Expected loss ~23kg → target weight ~77kg
- Starting weight 120kg: Expected loss ~27kg → target weight ~93kg
- Starting weight 150kg: Expected loss ~34kg → target weight ~116kg
These are averages — individual results vary significantly based on diet, activity levels, metabolic health and protocol adherence.
What Affects Retatrutide Results?
- Diet: Retatrutide reduces appetite but doesn’t enforce food choices. Users who complement it with whole foods and reduced ultra-processed food see better results
- Activity: Even moderate exercise (walking 8,000+ steps/day) improves outcomes significantly
- Dose: Higher doses produce better results — but always titrate slowly to the lowest effective dose
- Adherence: Missing doses reduces effectiveness. Once-weekly injection on the same day produces the most consistent results
- Starting weight: Higher starting BMI tends to correlate with larger absolute weight loss in kg, though the percentage is similar
Beyond Weight Loss — Other Results to Expect
- Blood pressure reduction (average 8.5 mmHg systolic in the trial)
- Improved fasting glucose and insulin sensitivity
- Reduction in waist circumference (average 25.7cm at 24mg)
- Improved lipid profile (triglycerides, LDL reduction)
- Reduced liver fat (particularly relevant for NAFLD)
- Improved cardiovascular risk markers
Start Your Retatrutide Protocol
Buy Synedica Retatrutide 40mg UK or Alluvi Retatrutide 40mg UK from £299/month with physician-supervised protocol included. WhatsApp us for a personalised protocol based on your starting weight and goals.
